On June 6, 2023, Joseph W. Marks notified the board of directors of Augmedix, Inc. (the Company) that he will resign from the Company's board of directors effective on the date of the Company's 2023 annual meeting of stockholders. Dr. Marks' resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices. Dr. Marks plans to continue to advise the Company after his departure from the board by serving as chair of the Company's AI advisory council, which the Company expects will be formed within the next two to three months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | -2.33% |
|
-1.18% | -85.64% |
06-04 | Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
05-29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.64% | 41.13M | |
+14.90% | 70.26B | |
+7.72% | 17.51B | |
+20.68% | 14.76B | |
+22.34% | 14.01B | |
+14.27% | 10.07B | |
-24.53% | 6.48B | |
-6.57% | 5.84B | |
+4.78% | 5.34B | |
+8.28% | 4.83B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Joseph W. Marks to Resign from the Augmedix's Board of Directors Effective on the Date of 2023 Annual Meeting of Stockholders